Your session is about to expire
← Back to Search
RM-718 (Cohort A2) for Hypothalamic Obesity
Study Summary
This trial aims to test the safety, side effects, and how the body processes RM-718 in both healthy individuals with obesity and patients with a specific type of obesity called hypothalamic obesity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are prospective patients still eligible to participate in this ongoing medical study?
"According to the details on clinicaltrials.gov, this research is actively enrolling subjects. The trial was first listed on 28th February 2024 and last revised on 15th February 2024."
What is the current number of participants being recruited for this medical study?
"Indeed, the details provided on clinicaltrials.gov affirm that this research project is actively seeking volunteers. Initially uploaded on February 28th, 2024, and subsequently updated by February 15th of the same year, the investigation aims to enroll a total of 90 participants at one designated site."
What is the level of safety associated with RM-718 (Cohort A2) in individuals?
"According to our assessment at Power, we have assigned a safety rating of 1 to RM-718 (Cohort A2) as it is currently in Phase 1 trial stage with scarce evidence backing its safety and effectiveness."
Which individuals are eligible to participate in this clinical research study?
"In this clinical study, inclusion criteria encompass enrolling 90 individuals aged between 12 and 65 who are grappling with hypothalamic obesity. Patients must meet the subsequent conditions: Both male and female participants in sound health within the age range of 18-55 at the time of screening., An elevated body mass index (BMI) equal to or greater than 30 kg/m2., Individuals exhibiting good overall health status with either normal or clinically insignificant findings during initial screenings., Strict adherence to a highly efficient contraception method alongside compliance with designated contraceptive protocols throughout the trial period., Male and female subjects diagnosed with hypothalamic obesity, aged from"
Is the research study open to individuals who are above 60 years old?
"The eligibility criteria specify an age range of 12 to 65 years for potential participants in this clinical study. There are a total of 178 studies targeting individuals under the age of 18 and 619 focused on those over the age of 65."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger